Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Microbes and Infectious Diseases ; 4(1), 2023.
Article in English | Scopus | ID: covidwho-2305026
3.
Energy Economics ; 117, 2023.
Article in English | Scopus | ID: covidwho-2244565
4.
Immunogenetics: a Molecular and Clinical Overview: Clinical Applications of Immunogenetics, Volume II ; 2:1-403, 2022.
Article in English | Scopus | ID: covidwho-2175668
5.
Asian Pacific Journal of Tropical Medicine ; 15(11):518-521, 2022.
Article in English | CAB Abstracts | ID: covidwho-2163867
6.
American Journal of Clinical Pathology ; 158(SUPP 1):S145-S145, 2022.
Article in English | Web of Science | ID: covidwho-2121955
8.
Journal of Islamic International Medical College ; 17(3):152-157, 2022.
Article in English | Scopus | ID: covidwho-2092277
9.
Immunogenetics: A Molecular and Clinical Overview A Molecular Approach to Immunogenetics ; : 1-392, 2021.
Article in English | Scopus | ID: covidwho-2075824
10.
Emerging Markets Review ; 51, 2022.
Article in English | Web of Science | ID: covidwho-1996140
11.
Pakistan Journal of Medical & Health Sciences ; 15(6):1948-1951, 2021.
Article in English | Web of Science | ID: covidwho-1399842
12.
Pakistan Journal of Medical and Health Sciences ; 15(5):1485-1487, 2021.
Article in English | EMBASE | ID: covidwho-1315215
13.
World Economy ; : 25, 2021.
Article in English | Web of Science | ID: covidwho-1255483
14.
Alternative Therapies in Health and Medicine ; 26:72-78, 2020.
Article in English | Web of Science | ID: covidwho-1070315
15.
Farmacia ; 68(6):966-969, 2020.
Article in English | Scopus | ID: covidwho-1005384
16.
Farmacia ; 68(5):771-778, 2020.
Article in English | Scopus | ID: covidwho-914995
18.
Eur Rev Med Pharmacol Sci ; 24(7): 4030-4034, 2020 04.
Article in English | MEDLINE | ID: covidwho-124272

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new strain that was discovered in 2019 and has not been previously identified in humans. On December 31st 2019 World Health Organization (WHO) was informed of a cluster of cases with pneumonia of unknown origin from Wuhan City, Hubei province of China. The WHO announced in February 2020 that COVID-19 is the official name of the coronavirus diseases. A total of 519,899 confirmed cases with 23,592 deaths linked to this pathogen as on March 27, 2020 have been reported. Due to increasing number of infected people across the continents and huge loss to human life, the WHO has declared the novel COVID-19 outbreak a pandemic. A pandemic is defined as the "worldwide spread" of a new disease. Currently, no COVID-19 specific treatments have been approved by the United States Food and Drug Administration (US-FDA). However, the current treatment options include hydroxychloroquine, tocilizumab, remdesivir, lopinavir-ritonavir (Kaletra®), and nitazoxanide. In recent past, some natural herbal compounds have demonstrated encouraging anti-viral properties. This article attempted to summarize available information on the reported anti-viral activity of some natural products.


Subject(s)
Coronavirus Infections/drug therapy , Phytotherapy , Plant Preparations/therapeutic use , Pneumonia, Viral/drug therapy , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2 , World Health Organization , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL